IP Library › Granted Patent US 12,232,962
Granted Patent B2
US 12,232,962 · App. 16/780,581 · Granted Feb 25, 2025

Methods and devices to reduce the risk of infection

Inventor: Scott Noblitt (Fort Collins, CO)
Assignee: ARMIS BIOPHARMA, INC.
A61F2/28A61L24/0015A61L24/0042A61L24/02A61L27/047A61L27/306A61L27/54A61L27/58A61L31/022A61L31/088A61L31/148A61L31/16A61F2002/30062A61L2300/404A61L2420/02A61L2420/06A61M1/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,232,962
App. No.
16/780,581
Granted
Feb 25, 2025
Kind
B2
Abstract

Articles for reducing the risk of infection, bearing, or containing an antimicrobial composition containing a solid-phase peroxyxcarboxylic acid metal salt are provided. Methods of reducing the risk of infection using the antimicrobial composition are also provided.

Claims (10)

1. An article configured for tissue contact, comprising a surface coated with an antimicrobial composition consisting of a dried solid-phase peracetic acid metal salt precipitate, wherein said metal salt precipitate is a reaction product of a mixture consisting of the polymer matrix support, hydrogen peroxide, peracetic acid, acetic acid and a basic metal salt selected from the group consisting of magnesium, zinc and lithium metal salts, wherein the basic metal salt is present in an amount effective to adjust the composition pH to between 3.5 and 7.5, and

the antimicrobial composition coating has a thickness of at least 10 μm.

2. The article according to claim 1 , wherein the acetic acid concentration in the mixture is 2.75 M.

3. The article according to claim 1 , wherein the basic metal salt is in a molar ratio to peracetic acid in the mixture from about 0.1:1 to about 10:1.

4. The article according to claim 1 , wherein the amount of peracetic acid in the mixture is from 0.1% to 85%.

5. The article according to claim 1 , wherein the basic metal salt is selected from the group consisting of a carbonate, hydroxide, oxide, acetate or formate metal salt, or a metal salt of an organic acid corresponding to the reduced form of the peracetic acid.

6. The article according to claim 1 , wherein the article is an implant.

7. The article according to claim 6 , wherein the implant is bioabsorbable.

8. The article according to claim 1 , wherein the surface is coated with a second coating, and the antimicrobial composition coating is applied on top of the second coating.

9. The article according to claim 1 , wherein the polymer matrix support is a polyethylene glycol.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2020
From: NOBLITT, SCOTT
To: ARMIS BIOPHARMA, INC.
Reel/Frame 053104/0513 →
Continuity (2)
Provisional Application 62800702 · Feb 4, 2019
Related Publication 20200246511A1 · Aug 6, 2020
References Cited (9)
US 5376120A · Sarver · 1994 [cited by examiner]
US 5423859A · Koyfman et al. · 1995 [cited by applicant]
US 9427417B2 · Myntti · 2016 [cited by applicant]
US 20180000984A1 · Vogt · 2018 [cited by examiner]
EP 1663333B1 · 2018 [cited by applicant]
WO 2019010465 · 2019 [cited by applicant]
Sriprapha et al., A Study of Mechanical Properties of Bone Cement Containing Micro- and Nano-Hydroxyapatite Particles, Apr. 13, 2018, Key Engineering Materials, vol. 766, pp. 117-121 (Year: 2018). [cited by examiner]
Mei, et al., J. Chem. Eng. Data (1995), 40 pp. 1168-1171. [cited by applicant]
International Search Report and Written Opinion dated Apr. 16, 2020 in Application PCT/US2020/016432. [cited by applicant]
Cited By (1)
US 12,702,655